News & Updates

Show Multimedia Only
Lumateperone improves depression symptoms in bipolar disorder Lumateperone improves depression symptoms in bipolar disorder

Lumateperone improves depression symptoms in bipolar disorder

26 Dec 2021

Treatment with 42-mg lumateperone daily leads to significant improvement in depression symptoms, with no serious safety issues, among patients with major depressive episodes associated with both bipolar I and II disorders, a study has shown.

26 Dec 2021
STEMI hospitalizations down during pandemic

STEMI hospitalizations down during pandemic

26 Dec 2021

There was a significant drop in hospitalizations for ST-segment elevation myocardial infarction (STEMI) during the coronavirus disease 2019 (COVID-19) pandemic, a recent study has found.

26 Dec 2021
Ticagrelor monotherapy following short-term DAPT more suitable for seniors with ACS

Ticagrelor monotherapy following short-term DAPT more suitable for seniors with ACS

25 Dec 2021

For older acute coronary syndrome (ACS) patients with implanted bioabsorbable polymer sirolimus-eluting stents, a strategy involving ticagrelor monotherapy after 3‐month dual antiplatelet therapy (DAPT) is better than ticagrelor‐based 12‐month DAPT, according to a post hoc analysis of the TICO* trial. Furthermore, the beneficial effect of ticagrelor monotherapy increases with age and is strongest among patients aged ≥64 years.

25 Dec 2021